Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tramadol vs Magnesium Sulphate for Post-Spinal Shivering
NCT06612996Phase 4Not yet recruiting
- Sponsor
- Al-Azhar University
- Start
- Oct 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of tramadol and magnesium sulfate in postanesthetic shivering (PAS) (3 arms), sponsored by Al-Azhar University. Primary endpoint: Shivering score. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
tramadolmagnesium sulfate
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on NCT06612996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06612996.